Rebecca Torguson

14.5k total citations · 1 hit paper
437 papers, 9.2k citations indexed

About

Rebecca Torguson is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rebecca Torguson has authored 437 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 326 papers in Cardiology and Cardiovascular Medicine, 265 papers in Surgery and 123 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rebecca Torguson's work include Coronary Interventions and Diagnostics (226 papers), Acute Myocardial Infarction Research (137 papers) and Cardiac Valve Diseases and Treatments (132 papers). Rebecca Torguson is often cited by papers focused on Coronary Interventions and Diagnostics (226 papers), Acute Myocardial Infarction Research (137 papers) and Cardiac Valve Diseases and Treatments (132 papers). Rebecca Torguson collaborates with scholars based in United States, Italy and Netherlands. Rebecca Torguson's co-authors include Ron Waksman, Lowell F. Satler, Augusto D. Pichard, Kenneth M. Kent, William O. Suddath, Zhenyi Xue, Itsik Ben‐Dor, Neil J. Weissman, Gabriel Maluenda and Michael A. Gaglia and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Rebecca Torguson

417 papers receiving 8.9k citations

Hit Papers

Late thrombosis in drug-e... 2004 2026 2011 2018 2004 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
    2004 1.0k citations Eugenio Stabile, Édouard Cheneau et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca Torguson United States 45 6.7k 5.9k 2.4k 2.3k 1.3k 437 9.2k
Lorenz Räber Switzerland 51 6.4k 1.0× 5.9k 1.0× 2.3k 1.0× 1.8k 0.8× 914 0.7× 348 9.2k
William O. Suddath United States 42 5.4k 0.8× 5.5k 0.9× 2.4k 1.0× 1.8k 0.8× 500 0.4× 249 7.8k
Giuseppe Sangiorgi Italy 57 6.4k 1.0× 6.7k 1.1× 3.3k 1.4× 4.1k 1.7× 902 0.7× 256 11.5k
Marie‐Claude Morice France 43 8.5k 1.3× 7.7k 1.3× 4.0k 1.6× 2.0k 0.9× 727 0.6× 184 10.6k
James Hermiller United States 49 7.1k 1.1× 8.0k 1.3× 2.7k 1.1× 3.2k 1.4× 1.5k 1.2× 224 11.6k
Alaide Chieffo Italy 60 9.1k 1.4× 8.4k 1.4× 4.7k 1.9× 2.9k 1.3× 1.8k 1.4× 401 12.7k
Gerrit‐Anne van Es Netherlands 31 6.5k 1.0× 6.2k 1.0× 2.8k 1.2× 1.7k 0.7× 720 0.6× 56 8.3k
Mark Turco United States 42 6.3k 0.9× 6.7k 1.1× 3.1k 1.3× 2.0k 0.9× 342 0.3× 102 9.2k
Marie‐Angèle Morel Netherlands 27 10.0k 1.5× 10.0k 1.7× 5.2k 2.1× 2.9k 1.3× 1.3k 1.0× 47 13.1k
Annapoorna Kini United States 44 4.7k 0.7× 5.2k 0.9× 2.4k 1.0× 2.0k 0.8× 724 0.6× 428 7.4k

Countries citing papers authored by Rebecca Torguson

Since Specialization
Citations

This map shows the geographic impact of Rebecca Torguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Torguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Torguson more than expected).

Fields of papers citing papers by Rebecca Torguson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Torguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Torguson. The network helps show where Rebecca Torguson may publish in the future.

Co-authorship network of co-authors of Rebecca Torguson

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Torguson. A scholar is included among the top collaborators of Rebecca Torguson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Torguson. Rebecca Torguson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chezar‐Azerrad, Chava, Anees Musallam, Corey Shea, et al.. (2021). One-Year Outcomes After Treatment of Ostial In-Stent Restenosis in Left Circumflex Versus Left Anterior Descending or Right Coronary Artery. The American Journal of Cardiology. 151. 45–50. 4 indexed citations
2.
Shah, Ankit B., Rebecca Torguson, Umar Ali Khan, et al.. (2021). Cardiovascular risk among ultra-endurance runners. The Journal of Sports Medicine and Physical Fitness. 61(12). 1700–1705. 3 indexed citations
3.
Musallam, Anees, Chava Chezar‐Azerrad, Rebecca Torguson, et al.. (2020). Procedural Outcomes of Patients Undergoing Percutaneous Coronary Intervention for De Novo Lesions in the Ostial and Proximal Left Circumflex Coronary Artery. The American Journal of Cardiology. 135. 62–67. 11 indexed citations
4.
Yerasi, Charan, Brian C. Case, Brian J. Forrestal, et al.. (2020). Risk of Mortality with Paclitaxel Drug-Coated Balloon in De Novo Coronary Artery Disease. Cardiovascular revascularization medicine. 21(4). 549–555. 2 indexed citations
5.
Yerasi, Charan, Yuefeng Chen, Brian C. Case, et al.. (2020). Treatment of Patients With Recurrent Coronary In-stent Restenosis With Failed Intravascular Brachytherapy. The American Journal of Cardiology. 142. 44–51. 2 indexed citations
6.
Gajanana, Deepakraj, William S. Weintraub, Paul Kolm, et al.. (2019). Trends in Death Rate 2009 to 2018 Following Percutaneous Coronary Intervention Stratified by Acuteness of Presentation. The American Journal of Cardiology. 124(9). 1349–1356. 9 indexed citations
7.
Khalid, Nauman, Toby Rogers, Evan Shlofmitz, et al.. (2019). Overview of the 2018 US Food and Drug Administration Circulatory System Devices Panel Meeting on Device-Based Therapies for hypertension. Cardiovascular revascularization medicine. 20(10). 891–896. 5 indexed citations
8.
Gajanana, Deepakraj, Toby Rogers, Micaela Iantorno, et al.. (2018). Antiplatelet and anticoagulation regimen in patients with mechanical valve undergoing PCI – State-of-the-art review. International Journal of Cardiology. 264. 39–44. 3 indexed citations
9.
Waksman, Ron, Kyle Buchanan, M. Chadi Alraies, et al.. (2018). IN-STENT RESTENOSIS OF DRUG-ELUTING STENTS COMPARED TO A MATCHED GROUP OF PATIENTS WITH DE NOVO CORONARY ARTERY STENOSIS. Journal of the American College of Cardiology. 71(11). A1033–A1033. 3 indexed citations
10.
Kiramijyan, Sarkis, Edward Koifman, Federico M. Asch, et al.. (2015). Impact of Functional Versus Organic Baseline Mitral Regurgitation on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Replacement. The American Journal of Cardiology. 117(5). 839–846. 20 indexed citations
11.
Loh, Joshua P., Pieter R. Stella, Giuseppe Sangiorgi, et al.. (2013). CRT-1 Paclitaxel Drug-coated Balloon For The Treatment Of Drug-eluting Stent In-stent Restenosis: Subanalysis Results Of The Valentines I Trial. JACC: Cardiovascular Interventions. 6(2). S1–S1.
12.
Alli, Oluseun, Charanjit S. Rihal, Rakesh M. Suri, et al.. (2013). TCT-747 Transcatheter Aortic Valve Replacement: Assessment of the Learning Curve Based on the PARTNER Trial. Journal of the American College of Cardiology. 62(18). B227–B228. 2 indexed citations
13.
Mahmoudi, Michael, Peter C. Hill, Zhenyi Xue, et al.. (2011). Patients With Severe Asymptomatic Carotid Artery Stenosis Do Not Have a Higher Risk of Stroke and Mortality After Coronary Artery Bypass Surgery. Stroke. 42(10). 2801–2805. 35 indexed citations
14.
Wakabayashi, Kohei, Cédric Delhaye, Gabriel Maluenda, et al.. (2010). Prognosis of Asymptomatic Coronary Artery Disease After Percutaneous Coronary Intervention. The American Journal of Cardiology. 105(11). 1507–1512. 3 indexed citations
15.
Maluenda, Gabriel, Gilles Lemesle, Itsik Ben‐Dor, et al.. (2009). Impact of intravascular ultrasound guidance in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. 75(1). 86–92. 27 indexed citations
16.
Slottow, Tina L. Pinto, Laurent Bonello, Mickey Scheinowitz, et al.. (2009). Prevalence of Aspirin and Clopidogrel Resistance Among Patients With and Without Drug-Eluting Stent Thrombosis. The American Journal of Cardiology. 104(4). 525–530. 46 indexed citations
17.
Ben‐Dor, Itsik, Ron Waksman, Lowell F. Satler, et al.. (2009). A further word of caution before using the internal mammary artery for coronary revascularization in patients with severe peripheral vascular disease!. Catheterization and Cardiovascular Interventions. 75(2). 195–201. 6 indexed citations
18.
Torguson, Rebecca, Laurent Bonello, Teruo Okabe, et al.. (2008). Abstract 4456: The Impact of Nuisance Bleeding on Clopidogrel Compliance in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents. Circulation. 118. 1 indexed citations
19.
Kuchulakanti, Pramod K., William W. Chu, Rebecca Torguson, et al.. (2006). Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents. Circulation. 113(8). 1108–1113. 480 indexed citations
20.
Stabile, Eugenio, Édouard Cheneau, Timothy Kinnaird, et al.. (2004). Late thrombosis in cypher stents after the discontinuation of antiplatelet therapy. PubMed. 5(4). 173–176. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorenz Räber Breakdown of academic impact, for papers by William O. Suddath Breakdown of academic impact, for papers by Giuseppe Sangiorgi Breakdown of academic impact, for papers by Marie‐Claude Morice Breakdown of academic impact, for papers by James Hermiller Breakdown of academic impact, for papers by Alaide Chieffo Breakdown of academic impact, for papers by Gerrit‐Anne van Es Breakdown of academic impact, for papers by Mark Turco Breakdown of academic impact, for papers by Marie‐Angèle Morel Breakdown of academic impact, for papers by Annapoorna Kini
Rankless by CCL
2026